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ABSTRACT
Aims Objective of this study was to evaluate the 
feasibility of the non- invasive dye dilution method to 
quantify shunt size related to atrial septal defects (ASD).
The diagnostic accuracy of shunt size determination in 
ASD’s has been suboptimal with common non- invasive 
methods. We have previously developed a cost- effective 
and time- effective non- invasive dye dilution method. In 
this method, the indocyanine green solution is injected 
into the antecubital vein and the appearance of the dye is 
detected with an earpiece densitometer.
Methods and results We studied 192 patients with an 
ASD. Mean pulmonary blood flow/systemic blood flow 
(Qp/Qs) was measured with dye dilution technique and 
compared with following methods: Fick’s invasive oximetry 
(n=49), transoesophageal echocardiography (TEE) 
measuring ASD size (n=143) and cardiac MR (CMR) (n=9).
For the first 49 patients, Qp/Qs was 2.05±0.70 with the 
Fick’s invasive oximetry and 2.12±0.68 with dye dilution 
method with an excellent correlation between the two 
methods (R=0.902, p<0.001). In the second study sample, 
the ASD size by TEE was 15±6 mm on average, and 
the mean Qp/Qs 2.16±0.65 measured with dye dilution 
method with a good correlation between the methods 
(R=0.674, p<0.001). Qp/Qs measured with CMR was 
1.87±0.40 resulting in a good correlation with the dye 
dilution method (R=0.696, p=0.037).
Conclusion The dye dilution method with earpiece 
densitometer recording is a clinically feasible and reliable 
method to assess shunt size in ASDs.
INTRODUCTION
Atrial septal defect (ASD) is the most 
common uncorrected congenital heart defect 
in adults.1 It creates a left- to- right shunt at the 
atrial level leading to volume overload and 
right ventricular enlargement.2 Dilatation of 
the right ventricle (RV) and atrium on tran-
sthoracic echocardiography (TTE) usually 
raises a suspicion of an ASD. The diagnosis is 
usually confirmed on transoesophageal echo-
cardiography (TEE).
Decision to close ASD is primarily based 
on diagnosis of RV dilation by echocardiog-
raphy but in borderline cases there is a need 
for shunt size assessment.2 The semi- invasive 
TEE examination provides good visualisation 
of the atrial septum and is a reliable method 
to assess the size of the ASD but does not 
provide reliable shunt size. On the other 
hand, cardiac MR (CMR) provides a reliable 
shunt size and an estimation of the ASD loca-
tion and dimensions but is limited by cost and 
availability issues.3 There is an obvious need 
for a non- invasive, cost- effective and time- 
effective method for evaluating shunt size in 
patients with suspected ASD.
Shunt size can be assessed also by cath-
eterisation,4 5 CMR,3 6 radionuclide 
method,7 8 doppler echocardiography9 10 or 
the dye dilution method.11 12 Invasive oxim-
etric quantitation of shunting using Fick’s 
principle described in 19474 has been the 
gold- standard method for assessing the shunt 
size.13 However, the dye dilution method 
is considered equally accurate.14 Both the 
radionuclide method and echocardiography 
have suboptimal accuracy in the shunt size 
determination.15–17
The shunt size measured with dye dilu-
tion is an old method, nowadays rarely used. 
Classically, it has been an invasive method, 
detecting the appearance of the dye by 
continuous withdrawal through a densi-
tometer cuvette. The appearance of the dye 
Key questions
What is already known about this subject?
 ► Invasive oximetry has been the gold- standard meth-
od for shunt size assessment.
What does this study add?
 ► Non- invasive dye dilution has an excellent cor-
relation to invasive oximetry and to atrial sep-
tal defect size measured with transoesophageal 
echocardiography.
How might this impact on clinical practice?
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can also be detected non- invasively using an earpiece 
densitometer.18–21
The purpose of this study was to evaluate the efficacy of 
shunt size calculation using this non- invasive dye dilution 
method with indocyanine green solution and compare it 
to the gold standard of invasive oximetric quantitation 
of shunting using Fick’s principle. Second, we evaluated 
how well the measured shunt size correlates to the native 
and invasive stop- flow balloon measured size of the ASD 
on TEE. Third, we compared the dye dilution method 




Two separate populations were used (1) to evaluate dye 
dilution method against invasive oximetry and (2) to 
evaluate dye dilution method against ASD size measured 
on TEE. We included all the patients with measurable 
ASD and a left to right shunt. If there was no left- to- right 
shunt present, the defect was diagnosed as PFO and not 
included in the study.
For the first population, a total of 49 consecutive ASD 
patients aged 18–80 years old were assessed using dye 
dilution method and invasive oximetry. The dye dilu-
tion curves were measured during the catheterisation 
by injecting the indocyanine green solution into the 
inferior vena cava (IVC, 32 patients) or the right atrium 
(RA, 17 patients). Direct injection to IVC or RA was used 
instead of the standard antecubital injection since the 
measurements were done during the catheterisation. 
The appearance of the dye was detected with an earpiece 
densitometer.
For the second population, consecutive candidates of 
percutaneous or surgical ASD closure (n=143) aged 17–88 
years old were assessed by (1) calculating the shunt size 
with the non- invasive dye dilution method, (2) measuring 
both native ASD size with TEE and (3) invasively with a 
balloon stop- flow technique during 1999–2018. Dye dilu-
tion curves were performed a second time 12 months 
after the ASD closure. All patients had EKG, chest X- ray 
and transthoracic echocardiography performed before 
and after the closure. For nine patients in this popula-
tion, the shunt size was also measured with CMR.
Dye dilution
While patient laying still in supine position, a non- invasive 
dichromatic earpiece densitometer (an instrument which 
measures the concentration of dye in the blood by light 
absorption using two wavelengths) was placed on the left 
ear pinna and an arterializing warm- up period of 10 min 
was allowed before the measurements. Benzyl nicotinate 
lotion (10 mg/g) was used as a vasodilator. An intrave-
nous cannula (17–18 G), connected with a three- way 
stopcock and a 10 cm extension tube, was inserted into 
an antecubital vein. 0.3–0.5 mL of the 10 mg/mL Indocy-
anine green (Cardiogreen, Becton- Dickinson, MD, USA 
or ICG- pulsion, Pulsion Medical Systems AG, Germany) 
was first placed into the extension tube and then flushed 
rapidly with 15 mL of 0.9% NaCl solution.
ASD was defined as present if there was a character-
istic hump in the downslope of the main part of the dye 
dilution curve because of early recirculation (figure 1). A 
gamma- variate curve- fitting algorithm was used to deter-
mine the area under the primary portion according to 
Maltz and Treves.22 The exponential fit was used to sepa-
rate the systemic recirculation and determine the area 
under the shunt portion of the curve. The pulmonary- to- 
systemic flow ratio was calculated as (primary area+shunt 
area)/primary area.23
To minimise the error in the dye dilution at least 
two measurements were obtained, and the best quality 
curve was used in the analysis. The dye- dilution curves 
were analysed without knowledge of the results of other 
measurements of the patient.
The investigations were well tolerated and did not 
cause any adverse reactions to the subjects.
One of the authors of this paper (MV) designed the 
densitometer and the software for the computer anal-
ysis of the dye dilution curves and the oximeter record-
ings.18 20 The equipment became available for clinical use 
in 1993.
Invasive oximetry
Invasive oximetry measurements were done during cath-
eterisation. Blood samples were drawn from the pulmo-
nary artery (PA) (two samples), RV (two samples), RA 
(three samples: upper, mid and lower part), superior vena 
cava (SVC) (three samples: upper, mid and lower part), 
IVC (two samples) and a systemic artery. SVC samples 
were drawn according to Grossman: 1 cm, 3 cm and 5 
cm from the RA.24 A left- to- right shunt was determined 
present if there was a significant step up in the blood 
oxygen saturation in some of the samples. The location 
of the shunt was determined by the criteria of Dexter et 
al.4 The pulmonary and systemic blood flows (Qs) were 
calculated using the Fick’s principle.24
Qp:Qs = (SA O₂ – MV O₂)/(PV O₂– PA O₂)
Figure 1 Left side: normal dye dilution curve. Right side: 
dye dilution curve with Qp:Qs 1.8 left- to- right shunt. There 
is a characteristic hump in the downslope of the main part 
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Arterial oxygen saturation (SAO₂) was used instead of 
pulmonary venous (PV) saturation, since we did not have 
the PV samples drawn. Mixed venous saturation (MVO₂) 
in ASD was calculated using three samples from the SVC 
and two from the IVC: (3 x SVC+IVC)/4.25 The IVC in the 
equation is the mean saturation of the two IVC samples.
Cardiac MR
CMR studies were performed on a 1.5 T or 3T scanner 
(Siemens Magnetom Symphony 1.5 T or Avanto 1.5 T or 
Siemens Magnetom Skyra 3 T). Morphological evalua-
tion of cardiac shunts was provided by T1 spin echo black 
blood sequence. For assessing cardiac function and local-
isation of the shunt cine images were acquired by fast 
imaging with steady- state precession. Short axis stack and 
long- axis cine images were used to determine a differ-
ence between left and right ventricular stroke volumes to 
calculate shunt volume.
In addition, velocity encoded (VENC) phase contrast 
MR was used for quantification of vascular flow. VENC 
images were acquired perpendicular to the ascending 
aorta and main PA. Through- plane flow was assessed 
just above the pulmonary and aortic valves. Appropriate 
VENC was chosen (started with 150 ms). Shunt fraction 
was calculated by measuring the ratio of pulmonary blood 
flow (Qp) to Qs.
Statistical analysis
SPSS software (V.25, IBM) was used for the analysis. The 
variables were compared using Spearman’s bivariate 
correlation test and Fisher’s exact two- tailed test. In all 
statistical tests, a two- way significance level of <0.05 was 
considered significant. Bland- Altman analysis was used 
to further asses the correlation between the dye dilution 
and invasive oximetry.26 All values are presented as ±SD if 
not otherwise mentioned.
RESULTS
In the first population (table 1) the mean Qp/Qs 
measured with dye dilution was 2.12±0.68 and the Qp/
Qs measured with catheterisation was 2.05±0.70. The 
shunt sizes were strongly correlated between these two 
methods, R=0.902 and p<0.001 (figure 2). In the Bland- 
Altman analysis (figure 3) the mean difference (Qp/Qs 
dye dilution – Qp/Qs invasive oximetry) was 0.07, and 
the SD was 0.24.
In the second population, vast majority of patients had 
normal left ventricular ejection fraction (62%±10%) and 
normal diastolic function (table 1). Seventy- six per cent 
of these patients had tricuspid valve regurgitation, most 
of these were trivial or mild. Twenty had moderate regur-
gitation, and none were severe. Mean tricuspid valve 
regurgitation gradient was 30 mm Hg (range 14–66 mm 
Hg). Pulmonary valve regurgitation was observed in 20 
patients, two of those were moderate.
The mean size of the shunt measured with dye dilution 
was 2.16±0.65. The correlation between the shunt size 
and the ASD size was good (R=0.674, p<0.001) (figure 4). 
ASD diameter measured with a balloon at stop- flow was 
slightly bigger as expected (table 1). Correlation of stop- 
flow balloon measurements to shunt size measured with 
dye dilution was also good (R=0.667, p<0.001).
The shunt size also correlated with the echocardio-
graphic measurement of the combined area of the RV 
and the RA size (R=0.311, p<0.001), but not with tricuspid 
valve regurgitant gradient (R=0.179, p=0.78), nor age 
(R=−0.086, p=0.305).
The dye dilution was repeated 12 months after the ASD 
closure for 91 patients. In these measurements, the mean 
Qp:Qs was 1.09±0.18, ranging from 1.0 to 1.85. The lower 
detection limit for dye dilution is 1.15. In four patients 





Female (%) 59% (29)
BMI 26±4
Transthoracic echo parameters:
  LVEF (%) 62±8.5









Female (%) 76% (109)
BMI 26±5
Indication for measurement
  Shunt size 85% (121)
  Stroke 15% (22)
Atrial fibrillation (%) 11% (16)
RBBB or partial RBBB (%) 50% (72)
Transthoracic echo parameters
  LVEF (%) 62±10
  RV +RA area (cm2) 47±12




  ASD native size (mm) 16±6
  ASD invasive balloon measurement (mm) 20±6
Dye dilution Qp/Qs 2.16±0.65
CMR Qp/Qs 1.87±0.40
Variables presented as mean±SD or percentage (absolute number 
of patients).
ASD, atrial septal defect; BMI, body mass index; CMR, cardiac 
MR; LVEF, left ventricular ejection fraction; Qp, pulmonary blood 
flow; Qs, systemic blood flow; RA, right atrium; RBBB, right bundle 
branch block; RV, right ventricle.
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Qp/Qs was markedly above this value (Qp:Qs >1.3), indi-
cating that there was some shunt left after defect closure. 
In three of these cases, residual shunt was also seen in 
colour Doppler.
CMR was also performed for 47 patients because of 
the suspicion of a partially anomalous PV return or some 
other shunt defect. In nine of these patients, the shunt 
size was also measured with CMR. Qp/Qs measured with 
CMR was 1.87±0.40 resulting in a good correlation with 
the dye dilution method (R=0.696, p=0.037).
In 16 patients, the shunt size was measured with the 
radionuclide method in different hospitals around 
Finland. In this study, the radionuclide method had no 
correlation with ASD’s size (R=−0.30, p=0.919).
DISCUSSION
To our knowledge, this is the largest study comparing 
shunt size to ASD dimension measured with TEE, and the 
first study to compare the shunt size to ASD dimension 
in adult population. The shunt size measured with dye 
dilution method showed good correlation with the actual 
ASD size measured by TEE or TEE with balloon sizing. 
The shunt size measured both by gold standard inva-
sive oximetry and by non- invasive dye dilution showed 
an excellent agreement. Also, the agreement seems 
to be excellent across all sizes of shunt Qp:Qs values. 
Furthermore, dye dilution method showed good correla-
tion with CMR shunt size measurement.
Right ventricular (with or without atrial) enlargement 
is considered the most important indicator for ASD 
closure.2 This enlargement is thought to reflect a large 
enough shunt to strain the right side of the heart when 
no other obvious reason for the enlargement is present. 
Shunt size assessment is needed in borderline cases or 
in cases with elevated right- sided pressure. Shunt Qp:Qs 
ratio of 1.5 or larger is accepted to be significant enough 
to cause expansion of the right side, however, there is no 
strong evidence supporting this statement.27 There are no 
large data available to show which size of shunt can cause 
ventricular enlargement and which size of ASD’s should 
be closed. Studies only show that patients benefit from 
closure of ASD’s large enough to cause right ventricular 
enlargement.28–31
Closing smaller ASD’s has never been studied in an 
endpoint driven manner. A large retrospective Danish 
cohort showed that patients with ASD’s not fulfilling 
closure criteria have increased cardiac mortality and 
they would benefit from medical re- examination since 
the haemodynamic properties of an ASD can change 
with ageing.32 At this time, we do not know that which is 
the best method to determine patients in need for ASD 
closure and if we should close defects with small dimen-
sions and shunt sizes smaller than 1.5.
The shunt size is determined by the ASD dimensions, 
pressure gradient between left and right atria, ventricular 
compliance and cardiac output. Our study demonstrates 
that the shunt size correlates well with the dimensions of 
the ASD shown before only in a paediatric population.27 
The current study shows that ASD size explains more 
than 2/3′s of the shunt size. Having said this, our eval-
uations in above cardiac measurements are limited. We 
do not have neither actual pressure gradient between 
left and RA nor cardiac output values. However, tricuspid 
Figure 2 Correlation of dye dilution measured shunt size 
(y- axis) to invasive oximetric quantitation of shunting using 
Fick’s principle (x- axis). Qp:Qs, pulmonary blood flow/
systemic blood flow.
Figure 3 Bland Altman analysis comparing dye dilution 
measured shunt size and invasive oximetry measured 
shunt size. Dotted lines represent the upper and lower 
limits of agreement (−1.96 SD and +1.96 SD). Upper limit 
of agreement 0.55, lower limit of agreement −0.41. Qp, 
pulmonary blood flow; Qs, systemic blood flow.
Figure 4 Correlation of dilution dye measured shunt size 
(Qp/Qs) to ASD sized measured on transoesophageal 
echocardiography. ASD, atrial septal defects; Qp:Qs, 
pulmonary blood flow/ systemic blood flow.
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regurgitation peak gradient measured with TTE gives 
a good estimation of pulmonary pressure, and it was in 
most cases normal or only mildly elevated.
Non- invasive dye dilution method has many advan-
tages compared with other shunt size measurement tech-
niques. It provides accurate results agreeing with invasive 
oximetry. In our comparison to invasive oximetry the dye 
was injected into the IVC or the RA. We can assume that 
the dye acts similar way as the dye injected to the antecu-
bital vein.21
Dye dilution can detect shunt fractions as small as 
1.15.17 In detecting patent foramen ovale the sensitivity 
was reported to be 76% and specificity 100%.20 Interob-
server agreement of dye dilution detection in small 
shunts has previously shown to be excellent. The method 
is also time- efficient and cost- efficient. One measurement 
takes only about 15 min, and the price per study is rela-
tively low, being about one third of the price of the CMR 
in our hospitals price list.
The dye dilution method has also limitations. Frag-
mented dye boluses can cause erroneous results. Signif-
icant valve regurgitations may influence to the Qp:Qs 
value. In our material there were no significant valve 
regurgitations. In atrial fibrillation the variance of heart 
rate and stroke volume impacts the shape of the dye 
dilution curve. Thus, more measurements are needed 
to interpolate the mean value. Dye dilution gives a good 
estimate of shunt size but does not yield information 
regarding the location of the shunt in the cardiovascular 
system.
Invasive oximetry has been the standard method for 
assessing the Qp:Qs ratio in intracardiac shunts. The inva-
sive nature of the study is considered its biggest down-
side. Other limitations are lack of sensitivity, requirement 
of a cardiovascular steady state during sample collection, 
and calculation of MVO2: normal variability of blood 
oxygen saturation in the right heart chambers is strongly 
influenced by the magnitude of Qs.5 24 The cardiac 
output spontaneously varies at rest, which introduces 
inaccuracies, especially if there are delays between blood 
samplings at various sites.25
CMR is suggested as a good alternative for shunt size 
evaluation. It is available in the most hospitals; however, 
capacity and costs are the usual limiting factors to use 
it. Studies demonstrate good correlation in shunt size 
assessment between CMR and invasive oximetry, however, 
based on rather small populations (n=10–50).3 6 33–36 
Also, there are some limitations in using MRI for shunt 
size evaluation: interpretation of the shunt is difficult 
with irregular rhythms, pulmonary and aortic pathology 
disturb the calculations, Qp/Qs ratio is overestimated if 
the assessment of the systemic flow is done distal to the 
coronary ostia in the ascending aorta,35 and breathing 
can influence the values obtained by CMR.17 Regardless 
of the above limitations, CMR is widely used in shunt size 
evaluation.
In this study, no correlation between radionuclide 
angiography and ASD size was found. The radionuclide 
evaluations were performed in small medical centres, 
with a limited amount of evaluations annually. This may 
cause difficulties in executing and interpreting the radio-
nuclide measurement and may have influenced on our 
results.
This study has potential limitations. It was done in a 
retrospective manner and the study was not designed to 
compare dye dilution to CMR or radionuclide method, 
therefore, it is hard to make conclusions of superiority 
of one method over the others. Second, we employed 
two populations to show correlation both to the inva-
sive oximetry and to the ASD size measured with TEE. 
We acknowledge that haemodynamic parameters would 
be important in the study, however, these parameters are 
not available in either of the populations. In 12 months 
control visit four patients had a significant residual shunt, 
however, they did not undergo additional tests to quan-
tify residual shunt seen in dye dilution.
CONCLUSION
The non- invasive dye dilution method with densitom-
eter recording is a clinically feasible, inexpensive and 
time- effective method to assess shunt size in ASDs. It has 
a good agreement to the gold- standard method and to 
ASD size.
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